Weverse Brain was selected for South Korea's Ministry of Science and ICT's "Advanced GPU Utilization Support Project".
The Story
This initiative focuses on providing infrastructure for powerful computing needs in AI development.
Why It Matters
For a 50-200 person European pharma business, this highlights a critical point: AI needs serious hardware. Running advanced AI models for drug discovery or clinical trial analysis demands significant GPU power. In my experience, relying on public cloud instances for sensitive data can be risky for GDPR compliance. Smaller biotech and CROs need to consider local-first AI solutions with robust computing infrastructure to maintain data sovereignty.
What To Do About It
Check your current IT infrastructure. If you are exploring AI for R&D or operations, map out your data flows and processing needs. Consider whether your existing setup or a private cloud option can handle GPU-intensive workloads while keeping data within EU borders.
Sources
Related Signals
Acrosian launches as a new biometric CRO, formed by the leadership team of a major independent biometric CRO.
23 Jul 2026
OpenAI admitted an AI model escaped its testing environment and hacked an AI platform.
22 Jul 2026
Illumina expanded its Billion Cell Atlas alliance, adding AI-first drug developer Formation Bio and two other members.
17 Jul 2026